Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2015

View Archived Issues

Indivior presents phase III results for once-a-month risperidone in schizophrenia

Portola collaborates with Ora on development of PRT-2761 for ophthalmic diseases

Specific Treg inhibition enhances antitumoral effect of DC vaccination in HCC

NanoString Technologies and CITN collaborate on biomarkers for cancer immunotherapy

Pacific Biosciences achieves new milestone in Roche collaboration

World Lupus Day May 10th: Natural product astilbin shows promise in animal model

Transition Therapeutics licenses SARM TT-701 from Lilly

Silver Creek Pharmaceuticals receives grant to develop Smart Growth Factors

Alexion to acquire Synageva

Lundbeck updates progress of first quarter 2015

Preclinical and first clinical data reported for cancer candidate PQR-309

Transplant Genomics awards grant to study organ transplant biomarkers

Symbiomix Therapeutics reports results from phase II trial of SYM-1219 in bacterial vaginosis

BGB-283 shows promising antitumor activity

Phosphate Therapeutics releases phase II results for PT-20 in hyperphosphatemia

EMA committee recommends approval of new Orfadin formulations

Takeda patents OX1 receptor antagonists

Zealand Pharma and Boehringer Ingelheim disclose glucagon analogues

Hospital for Special Surgery reports compositions to promote tissue mineralization

Roche reports development of tau-PET imaging agents

Retinitis pigmentosa gene slc7a14 plays relevant role in vision

Venetoclax receives breakthrough therapy designation in 17p deletion CLL

Sumitomo Dainippon Pharma and Takeda terminate lurasidone agreement

Gilead Sciences acquires EpiTherapeutics

Sucampo's cobiprostone granted fast track designation for oral mucositis

PlasmaTech to acquire Abeona Therapeutics

Zykadia approved in E.U. for ALK-positive NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...